How Tirzepatide Targets Both GIP And GLP-1 Pathways Tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for weight loss, is a newer medication with a unique dual action
But first, it helps to understand why muscle loss during semaglutide therapy is such a significant issue
FAQs What is GLP-1 microdosing
This is the most frequently reported effect and is inherent to GHRP-6's mechanism Mild water retention and peripheral edema, particularly during the first 2 to 4 weeks Transient flushing, warmth, or dizziness immediately post-injection Injection site reactions (redness, minor swelling) Less Common: Tingling or numbness in the extremities (hands and feet), related to GH-mediated fluid shifts Head rush or lightheadedness shortly after administration Drowsiness, particularly with evening doses Dose-Dependent (above saturation dose): Elevated cortisol via ACTH stimulation
It showed that those taking retatrutide lost up to 17.5%, or 41 lb of their baseline body weight at 24 weeks